FLAGSTAFF, Ariz.--(BUSINESS WIRE)--W. L. Gore & Associates, Inc. (Gore) today announced the first patient implant of the GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System after ...
FLAGSTAFF, Ariz.--(BUSINESS WIRE)--W. L. Gore & Associates, Inc. (Gore) today announced the first implant of the GORE® TAG® Thoracic Branch Endoprosthesis (TBE) in the pivotal study. The patient was ...
FLAGSTAFF, Ariz.--(BUSINESS WIRE)--W. L. Gore & Associates, Inc. (Gore) announces the first U.S. implant of the GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System. The successful ...
April 1, 2005 — The U.S. Food and Drug Administration (FDA) has approved an endoprosthesis for the repair of descending thoracic aortic aneurysms; a catheter infusion system for the targeted delivery ...
Good news for W. L. Gore & Associates: The FDA has signed off on an expanded use for the privately held company's TAG thoracic endoprosthesis (pictured) for use in repairing aortic tears, the company ...
FLAGSTAFF, Ariz.--(BUSINESS WIRE)--W. L. Gore & Associates, Inc. (Gore) today announced the first patient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results